Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
BMJ Open
|
February 13, 2018
Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol
Ameeta Retzer, Thomas Keeley, Khaled Ahmed, et al.
The Oncologist
|
June 10, 2017
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study
Felicia T Roncolato, Florence Joly, Rachel O'Connell, et al.
Psycho-Oncology
|
June 22, 2019
Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation
Joachim Weis, Markus A Wirtz, Krzysztof A Tomaszewski, et al.
Journal of the National Cancer Institute
|
April 9, 2019
Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials
Derek Kyte, Ameeta Retzer, Khaled Ahmed, et al.
Gynecologic Oncology
|
November 7, 2017
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)
Felicia T Roncolato, Dominique Berton-Rigaud, Rachel O'Connell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
December 18, 2017
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer
Madeleine T King, Martin R Stockler, Rachel L O'Connell, et al.
Gynecologic Oncology
|
February 27, 2024
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer
Felicia Roncolato, Madeleine T King, Rachel L O'Connell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 21, 2010
Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)
Elfriede Greimel, Andy Nordin, Anne Lanceley, et al.
Health and Quality of Life Outcomes
|
October 10, 2024
An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26
Juan Ignacio Arraras, Johannes Giesinger, Omar Shamieh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 5, 2024
An international study of clinical, demographic, and competence-related determinants of communication with professionals
Juan Ignacio Arraras, Johannes Giesinger, Omar Shamieh, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
BMJ Open
|
February 13, 2018
Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol
Ameeta Retzer, Thomas Keeley, Khaled Ahmed, et al.
The Oncologist
|
June 10, 2017
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study
Felicia T Roncolato, Florence Joly, Rachel O'Connell, et al.
Psycho-Oncology
|
June 22, 2019
Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation
Joachim Weis, Markus A Wirtz, Krzysztof A Tomaszewski, et al.
Journal of the National Cancer Institute
|
April 9, 2019
Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials
Derek Kyte, Ameeta Retzer, Khaled Ahmed, et al.
Gynecologic Oncology
|
November 7, 2017
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)
Felicia T Roncolato, Dominique Berton-Rigaud, Rachel O'Connell, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
December 18, 2017
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer
Madeleine T King, Martin R Stockler, Rachel L O'Connell, et al.
Gynecologic Oncology
|
February 27, 2024
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer
Felicia Roncolato, Madeleine T King, Rachel L O'Connell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 21, 2010
Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)
Elfriede Greimel, Andy Nordin, Anne Lanceley, et al.
Health and Quality of Life Outcomes
|
October 10, 2024
An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26
Juan Ignacio Arraras, Johannes Giesinger, Omar Shamieh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 5, 2024
An international study of clinical, demographic, and competence-related determinants of communication with professionals
Juan Ignacio Arraras, Johannes Giesinger, Omar Shamieh, et al.
Page
of 8